Key result
PRKAG2 cardiomyopathy features 100% glycogen accumulation on endomyocardial biopsy versus none in controls.
Why the study?
Histopathological features of PRKAG2 cardiomyopathy have been reported only in a fragmentary manner, and systematic evaluation of its cardiac pathological features and diagnostic potential was needed.
Does histopathological and ultrastructural analysis of endomyocardial biopsy provide reliable diagnostic features for PRKAG2 cardiomyopathy compared to normal controls?
Case-Control (n=29)
Blinded outcome assessment
No
Does histopathological and ultrastructural analysis of endomyocardial biopsy provide reliable diagnostic features for PRKAG2 cardiomyopathy compared to normal controls?
Histological and ultrastructural analysis of right ventricular endomyocardial biopsies identifies a highly specific set of features—marked vacuolization and significant glycogen accumulation—that reliably distinguishes PRKAG2 cardiomyopathy from normal hearts, suggesting biopsy as a valuable diagnostic alternative where genetic testing is unavailable.
Answers are grounded in this paper and cite their sources.
Endomyocardial biopsy may aid PRKAG2 diagnosis when genetic testing is unavailable; extends prior reports but leaves open prospective validation.
BACKGROUND: The histopathological features of PRKAG2 cardiomyopathy have been reported in a fragmentary manner. OBJECTIVE: We aimed to systematically evaluate the cardiac pathological features of PRKAG2 cardiomyopathy in a large patient cohort and assess their diagnostic potential compared to genetic sequencing. METHODS: We conducted an observational, cross-sectional, case-control study including 18 patients with PRKAG2 cardiomyopathy and 11 heart transplant recipients as controls. All patients underwent percutaneous right ventricular endomyocardial biopsy. Tissue samples were analyzed using H&E staining, Periodic Acid-Schiff staining for glycogen, Masson's trichrome for fibrosis, and ultrastructural assessment by transmission electron microscopy. Statistical significance was set at p < 0.05 for all analyses. RESULTS: PRKAG2 cardiomyopathy hearts exhibited significant cardiomyocyte enlargement, normal-appearing mitochondria, extensive vacuolization of most myofibers, minimal interstitial fibrosis (only two patients had mild fibrosis), and no inflammatory cell infiltration. Transmission electron microscopy revealed abundant cytosolic glycogen, primarily in the perinuclear region, with additional deposits in intermyofibrillar and subsarcolemmal areas. This pronounced glycogen accumulation, consistently observed in all PRKAG2 patients, was absent in controls. CONCLUSION: Histological and ultrastructural examination of right ventricular endomyocardial biopsy samples reveals a distinct set of features that strongly suggest PRKAG2 cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Honorato-Sampaio et al. (2026) conducted a case-control in PRKAG2 cardiomyopathy (n=29). PRKAG2 gene mutation vs. Structurally normal heart transplant controls was evaluated on Glycogen accumulation detected by transmission electron microscopy (p=<0.0001). PRKAG2 cardiomyopathy was characterized by distinct ultrastructural features, including a 100% rate of glycogen accumulation on endomyocardial biopsy compared to 0% in transplant controls.
Synapse has enriched 10 related papers. Consider them for comparative context: